Regeneron Pharmaceuticals shares owned by Smithbridge Asset Management
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Smithbridge Asset Management
from 13F filings
Historical chart of Smithbridge Asset Management investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Smithbridge Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Smithbridge Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $3.4M | 5.4k | 634.23 |
| 2024-09-30 | $6.1M | 5.8k | 1051.24 |
| 2024-06-30 | $3.5M | 3.3k | 1051.03 |
| 2024-03-31 | $3.7M | 3.9k | 962.49 |
| 2023-12-31 | $3.6M | 4.1k | 878.19 |
| 2023-09-30 | $3.4M | 4.1k | 822.97 |
| 2023-06-30 | $3.1M | 4.4k | 718.63 |
| 2023-03-31 | $3.6M | 4.4k | 821.57 |
| 2022-12-31 | $3.1M | 4.3k | 721.47 |
More positions owned by Smithbridge Asset Management
View all positions for Smithbridge Asset Management